Initial experience of the levodopa–entacapone–carbidopa intestinal gel in clinical practice
M Öthman, E Widman, I Nygren, D Nyholm - Journal of Personalized …, 2021 - mdpi.com
Patients in fluctuating stages of Parkinson's disease (PD) require device-aided treatments.
Continuous infusion of levodopa–carbidopa intestinal gel (LCIG) is a well-proven option in …
Continuous infusion of levodopa–carbidopa intestinal gel (LCIG) is a well-proven option in …
Long-term effect and reasons for switching and combining device-aided therapies in Parkinson's Disease
D Georgiev, M Trost - Neurologia i Neurochirurgia Polska, 2025 - journals.viamedica.pl
Introduction. In the advanced stages of Parkinson's disease (PD), when standard drug
adjustments fail to sufficiently improve patients' quality of life, device-aided therapies (DATs) …
adjustments fail to sufficiently improve patients' quality of life, device-aided therapies (DATs) …
From the gut to the brain and back: therapeutic approaches for the treatment of network dysfunction in Parkinson's disease
G Paolone - Frontiers in Neurology, 2020 - frontiersin.org
Parkinson's disease (PD) is a complex, multisystem, progressive, degenerative disorder
characterized by severe, debilitating motor dysfunction, cognitive impairments, and mood …
characterized by severe, debilitating motor dysfunction, cognitive impairments, and mood …
A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease
M Öthman, D Nyholm - Movement Disorders Clinical Practice, 2024 - Wiley Online Library
Background Levodopa‐entacapone‐carbidopa intestinal gel (LECIG) infusion was
introduced to the Swedish market in 2019 for Parkinson's disease (PD) with motor …
introduced to the Swedish market in 2019 for Parkinson's disease (PD) with motor …
[PDF][PDF] Clinical profile of levodopa-carbidopa-entacapone intestinal gel infusion in patients with advanced Parkinson's disease
KA Atanasova-Ivanova, SI Hristova-Chakmakova… - Folia Medica, 2023 - foliamedica.bg
Introduction: Parkinson's disease in its advanced stage is a progressive condition that can
be treated with levodopa. The long-term complications of this treatment are difficult to …
be treated with levodopa. The long-term complications of this treatment are difficult to …
[HTML][HTML] Efficacy and Safety of Safinamide vs Opicapone as Adjuvant to Levodopa Therapy in Elderly with Parkinson's Disease: A Network Meta-Analysis
FM Aldian, MV Ariyanto… - Journal of Asian …, 2023 - jamsa.amsa-international.org
Introduction: Parkinson's disease (PD) becomes a significant health problem in the elderly.
This chronic and progressive neurodegenerative disease needs to be treated with …
This chronic and progressive neurodegenerative disease needs to be treated with …